Shanghai Chicmax Cosmetic (SEHK:2145) Valuation After Strong 2025 Earnings And Steady Dividend

Earnings jump and steady dividend put Shanghai Chicmax Cosmetic in focus Shanghai Chicmax Cosmetic (SEHK:2145) has drawn fresh attention after reporting higher full year 2025 sales and net income, alongside a proposed final dividend of RMB 0.75 per share, unchanged from 2024. See our latest analysis for Shanghai Chicmax Cosmetic. Despite the earnings and dividend news, the recent 30 day share price return of 14.81% and year to date share price return of 26.22% point to fading momentum. However, the 3 year total shareholder return of over 100% highlights how longer term holders have had a very different experience. If you are comparing Shanghai Chicmax Cosmetic with other names in the consumer space, it can be helpful to see how quality and growth look across a broader set of companies, including those in the 95 top founder-led companies So, with earnings and dividends holding up while the share price has seen a recent pullback, is Shanghai Chicmax Cosmetic now trading below what its fundamentals suggest, or is the market already pricing in future growth? Price-to-earnings of 16.1x: Is it justified? Shanghai Chicmax Cosmetic trades on a P/E of 16.1x, which sits slightly below both its estimated fair P/E of 19.2x and the peer average of 16.2x. The P/E ratio compares the HK$51.2 share price with the company’s earnings per share. It therefore reflects what investors are currently willing to pay for each unit of profit. For Shanghai Chicmax Cosmetic, several factors sit behind that number. Earnings grew 41.1% over the past year and have grown 39.9% per year over five years, with high quality earnings and a 40.2% return on equity. Forecast earnings growth of 17.5% per year and revenue growth of 17.1% per year, both ahead of the wider Hong Kong market, indicate that investors are paying for a business where profits are expected to keep expanding, even if growth is not classed as very high. Compared with the Asian Personal Products industry P/E of 21.3x, Shanghai Chicmax Cosmetic’s 16.1x looks cheaper in relative terms. In addition, the fair P/E estimate of 19.2x points to a level the market could potentially move toward if current earnings quality and growth trends persist. Explore the SWS fair ratio for Shanghai Chicmax Cosmetic Result: Price-to-earnings of 16.1x (UNDERVALUED) However, recent share price declines, along with heavy exposure to Mainland China revenue concentration, could quickly challenge confidence in the current valuation story. Find out about the key risks to this Shanghai Chicmax Cosmetic narrative. Another view from the SWS DCF model While the 16.1x P/E suggests Shanghai Chicmax Cosmetic looks inexpensive against peers and its fair ratio, the SWS DCF model points the other way. On this cash flow view, the HK$51.2 share price sits above an estimated value of HK$42.27, which implies the shares screen as overvalued instead. This kind of split verdict between earnings based and cash flow based approaches can matter for you as an investor. Growth and quality may justify paying up, but it also raises the question of how much valuation risk you are comfortable carrying if sentiment cools from here. Look into how the SWS DCF model arrives at its fair value. Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Shanghai Chicmax Cosmetic for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 235 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps With mixed signals on value and sentiment, it makes sense to look under the hood yourself, weigh the trade off between upside and risk, and see the 3 key rewards and 1 important warning sign Looking for more investment ideas? If you only stop at one company, you risk missing other opportunities that might suit your style even better. Try widening your net with a few focused screens. Target consistent cash generation by scanning for businesses with stronger balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (384 results). Hunt for potential value by checking companies that combine quality metrics with pricing that screens as attractive in the 235 high quality undervalued stocks. Spot early stage opportunities backed by solid financials by reviewing the 226 elite penny stocks with strong financials before the market pays closer attention. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.